Ketoflam-P Tablet is a combination analgesic formulation containing Flupirtine 100 mg and Paracetamol 325 mg, designed for the management of moderate to severe pain. Flupirtine, a non-opioid muscle relaxant and analgesic, acts centrally by modulating neuronal excitability through selective potassium channel opening, thereby providing effective relief from muscle spasms and neuropathic pain. Paracetamol, a widely used antipyretic and analgesic agent, exerts its effect primarily through central inhibition of prostaglandin synthesis, contributing to pain relief and fever reduction. The synergistic action of these two active ingredients makes Ketoflam-P effective in treating musculoskeletal pain, postoperative pain, and other acute pain conditions. This combination offers the advantage of enhanced analgesic efficacy with a potentially lower risk of adverse effects compared to higher doses of single agents. Ketoflam-P should be used under medical supervision, with caution advised in patients with hepatic or renal impairment, as well as those with a history of hypersensitivity to either component. It is contraindicated in individuals with severe liver dysfunction or porphyria. Common side effects may include gastrointestinal discomfort, dizziness, or allergic reactions. Proper dosing and duration of therapy should be adhered to, ensuring optimal therapeutic outcomes while minimizing risks.